Announcements
Sidley Represents Novo Holdings in a Growth Capital Investment in Oxford Nanopore Technologies
August 2, 2024
Sidley represented Novo Holdings, a leading international life science investor, on their £50 million investment in Oxford Nanopore Technologies, the leading UK-listed company behind a new generation of molecular sensing technology based on nanopores.
Novo Holdings will invest £50 million in Oxford Nanopore as part of an equity issue and intends to add to this investment over time, with further purchases in the secondary market subject to availability and price (among other factors).
The Sidley team was led by Private Equity partner Robert Darwin, supported by partner James Wood, counsel Ed Perry, and associate Jessica Edwards (M&A and Private Equity).
Novo Holdings will invest £50 million in Oxford Nanopore as part of an equity issue and intends to add to this investment over time, with further purchases in the secondary market subject to availability and price (among other factors).
The Sidley team was led by Private Equity partner Robert Darwin, supported by partner James Wood, counsel Ed Perry, and associate Jessica Edwards (M&A and Private Equity).
Contacts
Offices
Capabilities
Suggested News & Insights
Sidley Elects Partnership Class of 29 and Counsel Class of 15 Across Europe and U.S.December 11, 2025Sidley Represents Lido Advisors in Its Partnership With Stuart Chaussée & AssociatesDecember 10, 2025Sidley Represents Lumexa Imaging in US$462.5 Million Initial Public OfferingDecember 10, 2025Sidley Represents Capricor Therapeutics in US$172.5 Million Common Stock OfferingDecember 10, 2025Sidley Advises Bessemer Investors on Strategic Investment in XanitosDecember 9, 2025Sidley Advises Ancala on Acquisition of U.S. Chemical Infrastructure PortfolioDecember 4, 2025
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory